SRNESorrento Therapeutics, Inc.

About Sorrento Therapeutics, Inc. (SRNE)

Sorrento Therapeutics, Inc. (SRNE) is a Biotechnology company headquartered in San Diego, CA, United States whose shares trade over-the-counter on the Expert Market tier.

Sorrento Therapeutics, Inc. (STI) provides access to its novel and proprietary technology platform for the construction of fully human antibody libraries, the STI Technology. The STI Technology applies RNA transcription for the amplification of human immunoglobin variable domain sequences.

SRNE key facts

Ticker symbol

SRNE

Market tier

Expert Market

Sector

Healthcare

Industry

Biotechnology

Headquarters

San Diego, CA, United States

Country of incorporation

US

Year of incorporation

1989

Estimated market cap

$496.2K (as of Apr 10, 2025)

Shares outstanding

551,281,154

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Latest filing

8K Report (Nov 3, 2023)

Sorrento Therapeutics, Inc. leadership

• Henry Ji — President, CEO
• Richard G. Vincent — CFO, Secretary
• George Uy — Chief Commercial Officer
• Vuong Trieu — Chief Scientific Officer

Explore more: Biotechnology stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with S